Papillary intralymphatic angioendothelioma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:458768D48.1
Who is this for?
Show terms as
15Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Papillary intralymphatic angioendothelioma (PILA), also known as Dabska tumor or endovascular papillary angioendothelioma, is an extremely rare vascular tumor that arises from the cells lining lymphatic vessels. It is classified as a borderline (low-grade malignant) vascular tumor, meaning it has the potential to behave aggressively in some cases but generally follows a relatively indolent (slow-growing) course. The tumor most commonly appears as a painless, slow-growing mass in the skin or soft tissues, often in the arms or legs, though it can occur in other locations including the head, neck, spleen, or bone. PILA typically presents as a firm, bluish or reddish nodule under the skin that may gradually enlarge over weeks to months. In some cases, the overlying skin may appear discolored or swollen. The tumor can sometimes involve nearby lymph nodes, which is why careful evaluation is important after diagnosis. While distant spread (metastasis) is rare, local recurrence after removal has been reported in some patients. Treatment usually involves complete surgical removal of the tumor with clear margins. Because of its rarity, there is no standardized chemotherapy or radiation protocol, though these may be considered in cases where the tumor cannot be fully removed or has spread. Long-term follow-up with imaging and clinical examinations is recommended to watch for recurrence. The overall prognosis is generally favorable when the tumor is completely excised, though ongoing monitoring is important.

Also known as:

Key symptoms:

Painless lump or mass under the skinBluish or reddish skin discoloration over the massSlow-growing soft tissue swellingSwollen lymph nodes near the tumorFirm nodule in the arm or legLocalized skin thickeningOccasional tenderness at the tumor siteSwelling that does not go away on its own

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Papillary intralymphatic angioendothelioma.

View clinical trials →

No actively recruiting trials found for Papillary intralymphatic angioendothelioma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Papillary intralymphatic angioendothelioma community →

Specialists

15 foundView all specialists →
LD
Larisa Debelenko
VALHALLA, NY
Specialist
2 Papillary intralymphatic angioendothelioma publications
FR
Fabrizio Remotti
NEW YORK, NY
Specialist
2 Papillary intralymphatic angioendothelioma publications
JP
J J Pozo-Kreilinger
Specialist
1 Papillary intralymphatic angioendothelioma publication
EP
E M Pena-Burgos
Specialist
1 Papillary intralymphatic angioendothelioma publication
EO
E J Ortiz-Cruz
Specialist
1 Papillary intralymphatic angioendothelioma publication
JC
J M Cordero-García
Specialist
1 Papillary intralymphatic angioendothelioma publication
IR
I Barrientos Ruiz
Specialist
1 Papillary intralymphatic angioendothelioma publication
MT
M Tapia-Viñe
Specialist
1 Papillary intralymphatic angioendothelioma publication
MP
M Peleteiro-Pensado
Specialist
1 Papillary intralymphatic angioendothelioma publication
DB
D Bernabéu-Taboada
Specialist
1 Papillary intralymphatic angioendothelioma publication
DM
Doaa Morrar
NEW YORK, NY
Specialist
1 Papillary intralymphatic angioendothelioma publication
AB
Ahmed Bendari
MANHASSET, NY
Specialist
1 Papillary intralymphatic angioendothelioma publication
SS
Sunder Sham
NEW YORK, NY
Specialist
1 Papillary intralymphatic angioendothelioma publication
PU
Pamela Unger
COLUMBUS, OH
Specialist
1 Papillary intralymphatic angioendothelioma publication
RA
Reham Al-Refai
MANHASSET, NY
Specialist
1 Papillary intralymphatic angioendothelioma publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Papillary intralymphatic angioendothelioma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Papillary intralymphatic angioendotheliomaForum →

No community posts yet. Be the first to share your experience with Papillary intralymphatic angioendothelioma.

Start the conversation →

Latest news about Papillary intralymphatic angioendothelioma

No recent news articles for Papillary intralymphatic angioendothelioma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Was the tumor completely removed with clear margins?,What is the risk of the tumor coming back, and how will we monitor for recurrence?,How often should follow-up imaging or examinations be scheduled?,Are there any signs or symptoms I should watch for that would require immediate attention?,Should I seek a second opinion from a specialist in rare vascular tumors?,Is there any role for additional treatment such as radiation or chemotherapy in my case?,Are there any clinical trials or research studies I could participate in?

Common questions about Papillary intralymphatic angioendothelioma

What is Papillary intralymphatic angioendothelioma?

Papillary intralymphatic angioendothelioma (PILA), also known as Dabska tumor or endovascular papillary angioendothelioma, is an extremely rare vascular tumor that arises from the cells lining lymphatic vessels. It is classified as a borderline (low-grade malignant) vascular tumor, meaning it has the potential to behave aggressively in some cases but generally follows a relatively indolent (slow-growing) course. The tumor most commonly appears as a painless, slow-growing mass in the skin or soft tissues, often in the arms or legs, though it can occur in other locations including the head, neck

How is Papillary intralymphatic angioendothelioma inherited?

Papillary intralymphatic angioendothelioma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Papillary intralymphatic angioendothelioma?

15 specialists and care centers treating Papillary intralymphatic angioendothelioma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.